Under construction – not a live service
Sign in
Enrolling by invitationPhase 1/2

Brain Pulse Stimulation to Support Recovery After Ischemic Stroke

Tests transcranial pulse stimulation at different energy levels in people after ischemic stroke.

Plain-language title generated from the registry record
Registry title: Safety, Dose-Finding, and Efficacy of Transcranial Pulse Stimulation for Post-Stroke Neurorehabilitation

Key facts

Where
Taipei, TaiwanSee the site
Phase
Phase 1/2

Where in Taiwan

  • Huan-JuiTaipei, TaiwanNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Taipei Hospital, Ministry of Health and Welfare
Trial code
NCT07784751
Record updated
25 August 2026
Original description
This study aims to evaluate the safety, tolerability, dose-response, and preliminary efficacy of transcranial pulse stimulation (TPS) for neurorehabilitation in patients with ischemic stroke. Participants will receive TPS at different energy levels in a dose-escalation design. Clinical and neurophysiological assessments will be conducted to evaluate changes in motor function, balance, quality of life, and brain activity.Read full original descriptionShow less

Safety, Dose-Finding, and Efficacy of Transcranial Pulse Stimulation in Post-Stroke Neurorehabilitation

This study aims to evaluate the safety, tolerability, dose-response, and preliminary efficacy of transcranial pulse stimulation (TPS) for neurorehabilitation in patients with ischemic stroke. Participants will receive TPS at different energy levels in a dose-escalation design. Clinical and neurophysiological assessments will be conducted to evaluate changes in motor function, balance, quality of life, and brain activity.

Age 20-80 years old; Confirmed ischemic stroke verified by MRI; Stroke onset between 1 month and 6 months prior to study enrollment; NIHSS score of 4-25 points, with quantifiable motor or language deficits; Completed acute medical care with stable vital signs.

ClinicalTrials.gov NCT07784751